NCT02122809View on ClinicalTrials.gov

Phase I Study of Chiauranib in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

June 30, 2016

Conditions
Solid Tumors
Interventions
DRUG

Chiauranib

Take orally

Trial Locations (1)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Sponsors
All Listed Sponsors
lead

Chipscreen Biosciences, Ltd.

INDUSTRY